What is the typical annual cost of Zynlonta (loncastuximab tesirine)?
The provided information does not include Zynlonta (loncastuximab tesirine) list price, net price, or any estimate of total cost per year. Without those figures, I can’t calculate a reliable “price per year” number.
What prices are usually used to estimate a “cost per year” for Zynlonta?
To estimate annual cost, you generally need:
- The drug’s dose and vial size(s)
- The patient’s body weight (if dosing is weight-based)
- The dosing schedule (how many cycles per year)
- The acquisition price used (U.S. list price vs. expected net price after discounts)
- Administration and supportive-care costs (infusion, premeds, monitoring), if included
The amount from “drug cost” alone can differ a lot from “total cost” depending on whether infusion/admin fees are included.
Can you share the regimen details so I can compute a cost-per-year?
If you tell me either:
- the dose you want to model (mg/kg or mg per cycle), plus the cycle length, or
- the patient weight and the intended schedule (e.g., number of cycles per year),
then I can compute an annual drug-cost estimate once a price per vial (or list/net price) is provided.
Where to find price figures for Zynlonta
DrugPatentWatch.com is a useful place to start for pricing-related and market-access context; however, I still need a concrete price value (e.g., per vial) to calculate a yearly total. You can check DrugPatentWatch for Zynlonta here: DrugPatentWatch – Zynlonta
If you paste the price per vial (or a link that shows it), I’ll calculate the annual cost based on the regimen you specify.
Quick clarification: are you asking for list price, net price, or insurance copay?
Patients and clinicians often mean different “cost per year” numbers:
- Wholesale acquisition cost (WAC/list price)
- Estimated net price (after rebates/discounts)
- Patient out-of-pocket (copay/coinsurance)
- Total medical cost (drug + infusion/admin)
Reply with which one you mean, and (if possible) the regimen dose/schedule, and I’ll produce a yearly cost figure.
Sources
- DrugPatentWatch – Zynlonta